Assignee
THERIVA BIOLOGICS INC
US·13 granted patents·10 pending applications·3 citations·filing 2019–2025
Top patents by PatentIndex Score
23 records- 0198US11608494B2Beta-lactamases with improved properties for therapyTHERIVA BIOLOGICS INC·Filed 2021·Granted Mar 21, 2023·2 cites·12 claims
- 0288US2023313166A1Beta-lactamases with improved properties for therapyTHERIVA BIOLOGICS INC·Filed 2023·Application pending·0 cites
- 0387US12274740B2Microbiome protection from oral antibioticsTHERIVA BIOLOGICS INC·Filed 2023·Granted Apr 15, 2025·0 cites·20 claims
- 0487US2023332128A1Modified beta-lactamases and methods and uses related theretoTHERIVA BIOLOGICS INC·Filed 2023·Application pending·0 cites
- 0587US2024197842A1Method and compositions for inhibiting or preventing adverse effects of oral antibioticsTHERIVA BIOLOGICS INC·Filed 2024·Application pending·0 cites
- 0686US11944669B2Method and compositions for inhibiting or preventing adverse effects of oral antibioticsTHERIVA BIOLOGICS INC·Filed 2023·Granted Apr 2, 2024·0 cites·19 claims
- 0782US12508304B2Alkaline phosphatase formulationsTHERIVA BIOLOGICS INC·Filed 2024·Granted Dec 30, 2025·0 cites·14 claims
- 0879US11883474B2Microbiome protection from oral antibioticsTHERIVA BIOLOGICS INC·Filed 2022·Granted Jan 30, 2024·0 cites·22 claims
- 0978US11981899B2E. coli-based production of beta-lactamaseTHERIVA BIOLOGICS INC·Filed 2022·Granted May 14, 2024·0 cites·7 claims
- 1075US11654184B2Alkaline phosphatase agents for treatment of radiation disordersTHERIVA BIOLOGICS INC·Filed 2019·Granted May 23, 2023·1 cites·15 claims
- 1174US2024082370A1Safe and effective beta-lactamase dosing for microbiome protectionTHERIVA BIOLOGICS INC·Filed 2023·Application pending·0 cites
- 1273US2023398194A1Methods and compositions for attenuating antibiotic resistanceTHERIVA BIOLOGICS INC·Filed 2023·Application pending·0 cites
- 1372US12472147B2Intestinal alkaline phosphatase formulationsTHERIVA BIOLOGICS INC·Filed 2023·Granted Nov 18, 2025·0 cites·18 claims
- 1471US12178917B2Beta-lactamase formulations and uses thereofTHERIVA BIOLOGICS INC·Filed 2020·Granted Dec 31, 2024·0 cites·16 claims
- 1571US12048735B2Alkaline phosphatase formulationsTHERIVA BIOLOGICS INC·Filed 2021·Granted Jul 30, 2024·0 cites·7 claims
- 1670US11872268B2Safe and effective beta-lactamase dosing for microbiome protectionTHERIVA BIOLOGICS INC·Filed 2022·Granted Jan 16, 2024·0 cites·8 claims
- 1768US2023310558A1Alkaline phosphatase agents for treatment of radiation disordersTHERIVA BIOLOGICS INC·Filed 2023·Application pending·0 cites
- 1867US2026048103A1Treatment or prevention of gastrointestinal immunotherapy side effectsTHERIVA BIOLOGICS INC·Filed 2023·Application pending·0 cites
- 1966US12318434B2Alkaline phosphate-based oncology treatmentsTHERIVA BIOLOGICS INC·Filed 2020·Granted Jun 3, 2025·0 cites·13 claims
- 2066US2025268993A1Alkaline phosphate-based oncology treatmentsTHERIVA BIOLOGICS INC·Filed 2025·Application pending·0 cites
- 2164US2025332230A1Ulcerative colitis treatments in selected patientsTHERIVA BIOLOGICS INC·Filed 2023·Application pending·0 cites
- 2262US2024252599A1Alkaline phosphatase-based treatments of celiac diseaseTHERIVA BIOLOGICS INC·Filed 2022·Application pending·0 cites
- 2361US11638699B2Intestinal alkaline phosphatase formulationsTHERIVA BIOLOGICS INC·Filed 2019·Granted May 2, 2023·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when THERIVA BIOLOGICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →